Heredodegenerative Disorders, Nervous System: Clinical Trials

61 trials for Heredodegenerative Disorders, Nervous System, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

37 completed, 9 unknown, 6 recruiting, 5 terminated. 61 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 461Completed 37, Unknown 9, Recruiting 6, Terminated 5, Active not recruiting 3, Withdrawn 1

Follow Heredodegenerative Disorders, Nervous System: new trials by email Literature Review of Heredodegenerative Disorders, Nervous System trials Research Report on Heredodegenerative Disorders, Nervous System

Trials (filtered) newest first · largest first

All 61 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Cardiac Magnetic Resonance and Echocardiography Study With Acoramidis
Acoramidis (AG10) oral tablet - Transthyretin Amyloidosis Cardiomyopathy (ATTR-CM), Amyloidosis
Phase 4RecruitingEidos Therapeutics, a BridgeBio company1502026-07-012026-07-29
Enavogliflozin for the Management of Patients With Amyloid CardiomyopaThy
Enavogliflozin 0.3mg, Placebo - Amyloid Cardiomyopathy
Phase 4RecruitingSeoul St. Mary's Hospital682026-01-062026-06-18
To Evaluate the Efficacy and Safety of Tafamidis Meglumine Soft Capsules in the Treatment of Adult Patients With Transthyretin Amyloid Polyneuropathy
Tafamidis Meglumine Soft Capsules - Transthyretin Amyloid Polyneuropathy
Phase 4RecruitingQilu Pharmaceutical Co., Ltd.152025-06-192025-07-30
Effect of Dapagliflozin Administration on the Apoptosis Levels of Patients With Acute Myocardial Infarction
Forxiga® 10 mg Film-Coated Tablet, manufactured by AstraZeneca Pharmaceuticals LP, USA for AstraZeneca Pharmaceuticals Co. Ltd., China imported by PT AstraZeneca Indonesia, Indonesia - Acute Myocardial Infarction (AMI), STEMI - ST Elevation Myocardial Infarction (MI)
Phase 4CompletedYoga Yudhistira402024-09-212025-02-27
D-Cycloserine for Serine Palmitoyltransferase Inhibition
D-cycloserine - Hereditary Spastic Paraplegia
Phase 4CompletedMassachusetts General Hospital12024-07-102026-04-21
Real World Effectiveness and Safety of Deutetrabenazine in Adult Chinese Participants With Huntington's Disease (HD) Chorea in China
Deutetrabenazine - Huntington's Disease, Chorea
Phase 4CompletedTeva Branded Pharmaceutical Products R&D LLC502024-02-022026-08-27
N-of-1 for Beta-Blockers in Cardiac Amyloidosis
Beta blocker - Cardiac Amyloidosis, Heart Diseases
Phase 4CompletedWeill Medical College of Cornell University142024-01-312026-07-29
Ultrasound Therapy In Cardiac Amyloidosis
Sonotherapy - Amyloidosis Cardiac
Phase 4RecruitingBrigham and Women's Hospital702023-08-312026-08-21
A Study to Investigate Behavioral and Other Co-Occurring Outcomes With Epidiolex as Add-On Therapy in Participants Aged 1 to 65 Years of Age With Tuberous Sclerosis Complex
Cannabidiol Oral Solution [Epidiolex] - Tuberous Sclerosis Complex Associated Neuropsychiatric Disease
Phase 4CompletedJazz Pharmaceuticals792023-06-292026-04-27
A Phase IV Study of Safety and Efficacy of Everolimus in Taiwanese Patients With Tuberous Sclerosis Complex Who Have Renal Angiomyolipoma (TSC-AML)
Everolimus - Renal Angiomyolipoma
Phase 4CompletedNovartis Pharmaceuticals42023-05-012026-10-29
Treating Leg Symptoms in Women With X-linked Adrenoleukodystrophy
Pramipexole, Placebo - Adrenoleukodystrophy, Restless Legs Syndrome
Phase 4Active not recruitingMassachusetts General Hospital242023-04-012026-07-01
A Study of ELAPRASE in Treatment-naïve Participants With Hunter Syndrome (Mucopolysaccharidosis [MPS] II)
ELAPRASE, Rituximab, Methotrexate - Mucopolysaccharidosis (MPS), Hunter Syndrome
Phase 4WithdrawnTakeda2023-02-282025-12-09
Gandouling in the Treatment of Wilson's Disease
Gandouling - Wilson's Disease
Phase 4UnknownJun Li2402023-01-012024-02-09
Real-World Effects of MC4R Agonist Therapy in BBS and Severe Genetic Obesity
Setmelanotide - Bardet Biedl Syndrome (BBS), Bardet Biedl Syndrome
Phase 4RecruitingTom Hühne2002023-01-012026-06-29
A Study of Elaprase in Children and Adults With Hunter Syndrome (Mucopolysaccharidosis II) in India
Elaprase - Hunter Syndrome
Phase 4CompletedTakeda52022-04-212025-01-23
The Impact of Electroacupuncture Combined With NGF on Clinical Effect and Functional Changes on Ischemic Stroke
Nerver growth factor (NGF) injection, Placebo injection, EA intervention - Ischemic Stroke
Phase 4UnknownThe Third Affiliated hospital of Zhejiang Chinese Medical University2882022-04-012022-07-28
Metformin in Children With Fragile X Syndrome
Metformin, Placebo - Fragile X Syndrome, Metformin
Phase 4CompletedChildren's Hospital of Fudan University372021-12-292026-08-25
Safety and Efficacy of Intravenous OAV101 (AVXS-101) in Pediatric Patients With Spinal Muscular Atrophy (SMA) (OFELIA)
OAV101 - Muscular Atrophy, Spinal
Phase 4CompletedNovartis Pharmaceuticals162021-11-042024-10-09
Evaluation of the Effects of Calcitriol's in the Neurological Symptoms of Friedreich's Ataxia Patients
Calcitriol, Blood analysis for frataxin's level measurement, Blood analysis for hypercalcemia's control - Friedreich Ataxia
Phase 4CompletedBerta Alemany202021-08-252023-10-23
Assessment of Potential for Chronic Liver Injury in Participants Treated With Epidiolex (Cannabidiol) Oral Solution
Cannabidiol - Lennox Gastaut Syndrome, Dravet Syndrome
Phase 4Active not recruitingJazz Pharmaceuticals1542021-07-072026-08-26

Showing 20 of 61. Sign in to see all of them.

Narrower conditions

Amyloid Neuropathies, Familial (9)  ·  Tourette Syndrome (9)  ·  Hereditary Sensory and Autonomic Neuropathies (7)  ·  Tuberous Sclerosis (6)  ·  Fragile X Syndrome (4)  ·  Huntington Disease (4)  ·  Mucopolysaccharidosis II (4)  ·  Tic Disorders (4)  ·  Tics (4)  ·  Hepatolenticular Degeneration (3)  ·  Amyloidosis (2)  ·  Angiomyolipoma (2)  ·  Bulbo-Spinal Atrophy, X-Linked (2)  ·  Friedreich Ataxia (2)  ·  Ischemic Stroke (2)

Broader conditions

Congenital, Hereditary, and Neonatal Diseases and Abnormalities (61)  ·  Nervous System Diseases (61)  ·  Genetic Diseases, Inborn (60)  ·  Neurodegenerative Diseases (52)  ·  Central Nervous System Diseases (32)  ·  Brain Diseases (29)  ·  Neuromuscular Diseases (23)  ·  Metabolic Diseases (21)  ·  Neurologic Manifestations (21)  ·  Nutritional and Metabolic Diseases (21)  ·  Peripheral Nervous System Diseases (20)  ·  Congenital Abnormalities (19)  ·  Pathological Conditions, Signs and Symptoms (19)  ·  Mental Disorders (17)

Interventions

idursulfase (4)  ·  Everolimus (3)  ·  Aripiprazole (2)  ·  Cannabidiol (2)  ·  Fluoxetine (2)  ·  Methylphenidate (2)  ·  Riluzole (2)  ·  Sirolimus (2)  ·  florbetapir (2)  ·  Acetaminophen (1)  ·  Adrenergic beta-Antagonists (1)  ·  Bupropion (1)  ·  Calcitriol (1)  ·  Citalopram (1)  ·  Clonidine (1)

Sponsors

Novartis Pharmaceuticals (4)  ·  Brigham and Women's Hospital (2)  ·  Jazz Pharmaceuticals (2)  ·  Massachusetts General Hospital (2)  ·  Medical College of Wisconsin (2)  ·  NYU Langone Health (2)  ·  Peking Union Medical College Hospital (2)  ·  Shire (2)  ·  Takeda (2)  ·  All India Institute of Medical Sciences, Bhubaneswar (1)  ·  Berta Alemany (1)  ·  Children's Hospital of Fudan University (1)  ·  Eidos Therapeutics, a BridgeBio company (1)  ·  Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) (1)  ·  HLB Pharmaceutical Co., Ltd. (1)

Countries

United States (32)  ·  China (10)  ·  Germany (5)  ·  United Kingdom (5)  ·  Canada (4)  ·  Brazil (3)  ·  Italy (3)  ·  Poland (3)  ·  Spain (3)  ·  Taiwan (3)  ·  Argentina (2)  ·  Belgium (2)  ·  Denmark (2)  ·  France (2)  ·  India (2)

Top investigators

Harvey S Singer, MD (2)  ·  Ahmad Yasa MD (1)  ·  Anil B Mukherjee, M.D. (1)  ·  Barbara J Coffey, M.D, M.S. (1)  ·  Barbara J Coffey, MD, MS (1)  ·  Berta Alemany Perna (1)  ·  Chris Mueller, MD (1)  ·  Craig A. Erickson, MD (1)  ·  Debasish Hota, MD, DM (1)  ·  Donald S Higgins, M.D. (1)  ·  Emily Stern, PhD (1)  ·  Eva Kohegyi, MD, MS (1)  ·  Florian S Eichler, MD (1)

Results publications

PMID 1135616, PMID 11383973, PMID 16829550, PMID 17006758, PMID 17159456, PMID 17459549, PMID 18791076, PMID 20218790, PMID 20568658, PMID 20579510, PMID 21059347, PMID 21357874, PMID 21639796, PMID 23152677, PMID 24595507, PMID 24799137, PMID 24841414, PMID 24997880, PMID 25205361, PMID 25681004, PMID 25770310, PMID 25870613, PMID 25902842, PMID 26077459, PMID 2855531, PMID 28626052, PMID 29487073, PMID 29729645, PMID 29984566, PMID 30762779, PMID 30782512, PMID 32316911, PMID 32740676, PMID 33262243, PMID 33305808, PMID 33488759, PMID 34770113, PMID 35482910, PMID 37621153, PMID 38428428, PMID 38866445, PMID 39033586, PMID 40104015, PMID 40538652, PMID 40903014, PMID 41291951, PMID 42435131, PMID 42477731, PMID 8054244

NIH funding

2023 (3), 2018 (2), 2014 (1), R01MH045802 (1), R24AG064025 (1), R34MH085844 (1), T32GM007748 (1)